Refine Search
(2)
(19)
(66)
(96)

Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2018’, provides an overview of the Leishmaniasis (Kala-Azar) pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2018’, provides an overview of the Cytomegalovirus (HHV-5) Infections pipeline landscape.

The report provides comprehensive information on the therapeutic...

Q Fever - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Q Fever - Pipeline Review, H1 2018’, provides an overview of the Q Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Q Fever, complete with analysi...

Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2018’, provides an overview of the Vancomycin-Resistant Enterococcus faecium Infections pipeline landscape.

The report provides comprehe...

Impetigo - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Impetigo - Pipeline Review, H1 2018’, provides an overview of the Impetigo pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Impetigo, complete with anal...

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2017

  • $2,000
  • September 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2017’, provides an overview of the Resistant Pseudomonas aeruginosa Infections pipeline landscape.

The report provides comprehensive information ...

Burkholderia Infections - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burkholderia Infections - Pipeline Review, H2 2016’, provides an overview of the Burkholderia Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Eastern Equine Encephalitis - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Eastern Equine Encephalitis - Pipeline Review, H2 2016’, provides an overview of the Eastern Equine Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Cerebral (Fatal) Malaria - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cerebral (Fatal) Malaria - Pipeline Review, H2 2016’, provides an overview of the Cerebral (Fatal) Malaria pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Bacterial Pneumonia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bacterial Pneumonia - Pipeline Review, H2 2016’, provides an overview of the Bacterial Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bacter...

Streptococcal Pneumonia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Streptococcal Pneumonia - Pipeline Review, H2 2016’, provides an overview of the Streptococcal Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections - Pipeline Review, H2 2016’, provides an overview of the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infe...

Dermatomycoses - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dermatomycoses - Pipeline Review, H2 2016’, provides an overview of the Dermatomycoses pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dermatomycoses, ...

Equine Encephalitis - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Equine Encephalitis - Pipeline Review, H2 2016’, provides an overview of the Equine Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Equine...

Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Genital Warts (Condylomata Acuminata) - Pipeline Review, H2 2016’, provides an overview of the Genital Warts (Condylomata Acuminata) pipeline landscape.

The report provides comprehensive information on the thera...